Students are expected to complete courses within each course’s suggested timeframe and participate in all scheduled course discussions and learning activities. Participation grades are assigned for most courses.
The maximum time allowed for the completion of the program is six (6) years from the date of enrolment in the program. In extenuating circumstances, a student may apply for additional time to complete his/her degree. A request to the Faculty’s Student Services office will be reviewed on a case-by-case basis and will require approval by the Director, Flex PharmD.
Students may seek permission for an academic leave (time away from UBC studies) of up to one year. Before taking leave, all students are strongly advised to discuss their plans with an academic advisor in the Faculty.
The passing mark for a course in the Faculty is 60%.
Any student whose academic record within the program is found to be unsatisfactory may be required to withdraw from the program.
Assessments, including but not limited to course assignments, may be refused a passing mark if they are noticeably deficient in the quality of written English, including the correct use of grammar, spelling, and punctuation.
Although satisfactory academic performance is a prerequisite to continuation, it is not the sole criterion in the consideration of the suitability of a student for continuation or graduation. The Faculty reserves the right to require a student to withdraw from the Faculty if that student is considered to be unsuited to proceed with the study or practice of pharmacy.
Supplemental examinations are not granted to students registered in the Flex PharmD program. A failure in any course requires the student to repeat the course at the next offering.
The Faculty’s Flex Student Progress & PLAR Committee monitors academic performance. Academic performance review occurs in two phases.
Phase 1: Completion of PHRM 451, 452, 453 and 461.
Phase 2: Completion of every 10-12 credits of coursework.
Students who fail more than two didactic or more than two experiential courses during the program, or who fail any course twice, will be required to discontinue their studies in the program.
Readmission after Being Required to Discontinue
Readmission after being required to discontinue is not guaranteed. Readmission decisions take into account program capacity, as well as the size and strength of the applicant pool in a given year. All students seeking to return after being required to discontinue must apply to be readmitted to the program and must provide evidence of the steps that they have taken to address the issues that led to being required to discontinue. The earliest a student may be readmitted is one full year (12 months) following the requirement to discontinue.
Students in the program have the opportunity to request credit for prior learning. Students can initiate a request for PLAR at any time after admission to the program; however, they are advised to select challenge option(s) within the first six months in the program. This is essential to meet application submission deadlines, to enable them to plan when they will register into courses associated with their challenge option, and to begin planning for portfolio development where required by the option selected. Challenge examination or Abbreviated Portfolio Assessment for selected courses only are the options available for didactic courses. Abbreviated or full portfolio assessments are the two options to challenge for credit for APPE, which are also called “practicum” (PHRM 491 – 496). If a PLAR challenge for a course or APPE is successful, the credits awarded are an acknowledgment that prior learning is substantially similar to what would be learned if the student took that course in the Flex PharmD Program. Credits that are awarded through PLAR appear on the student’s transcript.
The maximum credit can be attained through PLAR is 50% of the overall credits in the Flex PharmD program.
A student has the right to appeal a progress decision of the program to the Dean’s Advisory Committee on Student Appeals (pharmsci.ubc.ca/current-students/flex-pharmd-students).
For information on Senate Appeals on Academic Standing please refer to Appeal Procedure.